Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Enanta Pharmaceuticals Inc

NASDAQ: ENTA · Life Sciences · 3 alerts · CIK 1177648

Share price
$10.67Close, Nov 16
Market cap
$311M
Shares outstanding
29.13MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Enanta Pharmaceuticals Inc filings on SEC EDGAR ↗

7:15 AM ET 8-K
Leadership Change

Enanta Pharmaceuticals Leadership Change

Jay R. Luly, Ph.D., has announced his intention to retire as President and CEO of Enanta Pharmaceuticals by February 1, 2027, after 23 years of leadership. Simultaneously, the company appointed Tara L. Kieffer, Ph.D., to the newly created role of Chief Operating Officer to drive operational execution and strategic alignment.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.